Corgenix Medical, a worldwide developer and marketer of diagnostic test kits, has entered into a 10-year contract manufacturing agreement with EDP Biotech, a medical device company focused on the development and commercialization of immunodiagnostic tests for humans.

Corgenix will manufacture and supply the ColoMarker diagnostic test, a blood test developed to detect the early stages of colon cancer. Corgenix has announced the expansion of its contract services business unit and launched a dedicated contract services web site.

ColoMarker is a blood test designed to identify potential cases of early-stage colon cancer. ColoMarker requires no advance preparation by the patient such as fasting or colon cleansing and can be added to the panel of blood tests routinely performed at a patient's annual physical.